Morrison Foerster earned top honors at the 16th Annual Global Competition Review (GCR) Awards for its work in Avadel Pharmaceuticals v. Jazz Pharmaceuticals, which was recognized as Litigation of the Year (Non-Cartel Prosecution).
Morrison Foerster represented Avadel Pharmaceuticals in antitrust litigation against Jazz Pharmaceuticals. Avadel alleged that Jazz abused a restricted distribution drug system and improperly listed a related patent in the FDA’s Orange Book to maintain monopoly power and delay entry of an innovative new medicine. The case drew significant attention from regulators and the industry, including an amicus brief from the FTC summarizing the potential harms to competition associated with improper listings of patents in the Orange Book. With trial imminent, MoFo secured a global settlement, resolving all claims, delivering a $90 million payment and a perpetual worldwide license to relevant patents.
The MoFo team representing Avadel included Washington, D.C., partner and co-chair of the firm’s Global Antitrust Law practice group Alex Okuliar, San Francisco partners Daralyn Durie and Eliot Adelson, Los Angeles associate Henry Huttinger, San Francisco of counsel Margaret Webb, New York associate Mika Fitzgerald, Washington, D.C., associate Tyler Phelps, and San Francisco associate Helen He.
Morrison Foerster was also named a finalist for the Behavioral Matter of the Year – Europe award for its work representing Mazda in the European Commission’s cartel investigation concerning end-of-life vehicles (ELVs).
The GCR Awards, announced at a March 24 ceremony in Washington, D.C., honor leading antitrust lawyers, economists, enforcers, and matters from 2025.
Read more about Morrison Foerster’s award-winning antitrust work and the full list of honorees. (Subscription required).
Alexander OkuliarChair of Global Antitrust Law Practice Group
Eliot A. AdelsonPartner
Daralyn DuriePartner
Margaret A. WebbOf Counsel
Mika M. FitzgeraldAssociate
Helen HeAssociate
Henry HuttingerAssociate